A phase 2, double-blind, randomized, placebo-controlled, dose-escalation study to evaluate the efficacy, safety, and tolerability of naloxegol in patients with opioid-induced constipationLynn R. Webster, Mark Sostek, Lorianne K. Masuoka et al.|Pain|2013Cited by 116
Efficacy, Safety and Pharmacokinetics of Oral NKTR-118 in Patients with Opioid-Induced Constipation: Results of a Randomized, Double-blind, Placebo-controlled Phase 2 StudyLynn R. Webster, Teressa Patrick, Richard E. Blonsky et al.|The American Journal of Gastroenterology|2009Cited by 6
NKTR-118 Significantly Reverses Opioid-Induced ConstipationLynn R. Webster, Nektar Therapeutics, Sunita Dhar|Unknown|2009Cited by 5